Has Trupanion Finally Turned the Corner on Profitability
Trupanion (TRUP) achieved its first GAAP net income of $19.4 million in FY2025, marking a significant shift toward profitability after years of growth focus, with a robust 15% subscription-adjusted operating margin. The company's 2026 outlook projects revenue of $1.55–$1.58 billion and 19% adjusted operating income growth, driven by strategic pricing and cost efficiencies. Despite this positive turnaround, TRUP shares are trading near their 52-week low, potentially offering an entry point for investors bullish on the long-term pet insurance market.
Trupanion stock (US89832Q1094): insurance player in focus after sector spotlight and capital plan
Pet insurer Trupanion is gaining attention following fresh sector commentary and its ongoing capital and growth initiatives, as detailed in its Q1 2026 update. The company's subscription-based model for pet health insurance, which includes direct payment to veterinarians,
Stocks to Watch: Analyst Price Targets for TRUP, DLB, and WDFC as of May 2026 - News and Statistics
This article analyzes analyst price targets for three stocks: Trupanion (TRUP), Dolby Laboratories (DLB), and WD-40 (WDFC), as of May 2026. While Trupanion and Dolby Laboratories are presented with cautionary notes due to slow growth and financial concerns, WD-40 is highlighted for its substantial upside potential according to Wall Street analysts. The report emphasizes the importance of independent analysis despite potentially bullish analyst ratings.
Trupanion Inc stock (US89832Q1094): earnings reaction keeps pet insurance specialist in focus
Trupanion Inc. remains a key focus for investors following its latest quarterly results and updated outlook for the North American pet insurance market. The company operates a subscription-based model providing medical coverage for pets and differentiates itself through direct veterinary clinic payments and a long-term economic strategy focusing on pet lifetime value. Despite positive growth trends in the pet insurance industry, Trupanion faces risks related to underwriting, competition, and evolving regulations.
Trupanion Inc stock (US89832Q1094): earnings turnaround and cost focus keep investors alert
Trupanion Inc, a pet health insurer, has reported its first-quarter 2026 results, highlighting continued subscription revenue growth and a strong focus on cost discipline. The company is actively working towards sustainable profitability by improving margins and cash flow. Investors are closely monitoring Trupanion's ability to scale its subscription model profitably within the competitive insurance market.
Trupanion (TRUP) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Trupanion (TRUP) stock has shown a bearish trend, but a hammer chart pattern suggests a potential trend reversal. This technical indicator, combined with rising optimism among Wall Street analysts regarding the company's future earnings and its Zacks Rank #2 (Buy) status, indicates that bulls may soon gain control and push the stock higher. The article explains the hammer chart pattern and highlights the fundamental factors supporting a turnaround for TRUP.
Trupanion (TRUP) director awarded 4,031 restricted stock units with deferred settlement
Trupanion (TRUP) director Paulette R. Dodson was granted 4,031 restricted stock units (RSUs) on May 11, 2026, as part of her equity compensation. These RSUs will vest in four equal installments, beginning August 22, 2026, and concluding May 22, 2027, provided her continued service. Settlement of the RSUs is deferred until 60 days after her death, disability, or separation from service, or immediately upon a change of control.
Trupanion (TRUP) director Bradley S. Powell awarded 6,563 RSUs vesting through 2027
Trupanion director Bradley S. Powell was granted 6,563 restricted stock units (RSUs) which will convert into common stock on a one-for-one basis. These RSUs vest in four equal installments, beginning in August 2026 and concluding in May 2027, contingent on Powell's continued service. This transaction is a grant of stock-based compensation, not a direct stock sale or purchase.
Trupanion (TRUP) director Elizabeth McLaughlin receives 3,281 RSU grant
Trupanion director Elizabeth McLaughlin was granted 3,281 Restricted Stock Units (RSUs) on May 11, 2026. These RSUs will vest in four equal installments, contingent on her continued service, and she has elected deferred settlement, meaning the shares will not be issued until after her separation from service, death, disability, or a change of control. This grant is a form of equity compensation with a stated acquisition price of $0.00 per unit, contributing to her total holding of 3,281 RSUs post-transaction.
Director Rubin awarded 1,686 RSUs at Trupanion (TRUP) for board service
Howard E. Rubin, a director at Trupanion (TRUP), was granted 1,686 Restricted Stock Units (RSUs) on May 11, 2026, as compensation for his service on the boards of the company's wholly-owned subsidiaries. These RSUs will convert into common stock on a one-for-one basis and will vest in four equal installments on specific dates between August 2026 and May 2027, contingent on his continued service. This award is considered equity compensation rather than an open-market purchase.
Trupanion (TRUP) director Max Broden awarded 6,375 RSUs with deferred settlement
Trupanion director Max Broden was granted 6,375 Restricted Stock Units (RSUs) on May 11, 2026, which will convert to common stock on a one-for-one basis. The RSUs vest in four equal installments, but due to Broden not seeking re-election at the 2026 Annual Meeting, only one-quarter will vest immediately before the meeting, with the rest forfeited. Broden has chosen deferred settlement, meaning the vested RSUs will not settle into common stock until 60 days after his death, disability, separation from service, or a change of control.
Is Trupanion’s (TRUP) Return to Profitability A Turning Point For Its Long-Term Business Narrative?
Trupanion (TRUP) reported a net income of US$4.88 million and basic earnings per share of US$0.11 in Q1 2026, marking a return to profitability after a loss the previous year. This, coupled with its consistent profitability in Q4 and full year 2025, suggests a potential turning point for the company's investment narrative. The long-term success of Trupanion, a pet insurance provider, hinges on its ability to maintain a durable and profitable subscription model amidst evolving competition and veterinary costs.
Vanguard Group Inc. Cuts Holdings in Trupanion, Inc. $TRUP
Vanguard Group Inc. reduced its stake in Trupanion, Inc. by 1.4% during the fourth quarter, selling 48,592 shares. Despite analysts maintaining a "Hold" rating with an average target price of $42.25, Trupanion's latest quarterly results surpassed expectations with EPS of $0.11 and revenue up 12.3% year over year. The article also notes insider stock sales and provides an overview of other institutional investment changes in Trupanion.
Q1 Earnings Roundup: Trupanion (NASDAQ:TRUP) And The Rest Of The Property & Casualty Insurance Segment
This article provides a Q1 earnings roundup for Trupanion (NASDAQ:TRUP) and other Property & Casualty (P&C) insurance companies. It highlights Trupanion's strong revenue growth and beat on analysts' estimates, while also reviewing the performance of Stewart Information Services (NYSE:STC), Fidelity National Financial (NYSE:FNF), American Financial Group (NYSE:AFG), and Lemonade (NYSE:LMND). The P&C insurance sector is described as cyclical, influenced by premium rates, interest rates, and facing headwinds from climate change and "social inflation."
Trupanion stock hits 52-week low at $23.77 amid challenging year
Trupanion Inc. (TRUP) stock has fallen to a 52-week low of $23.77, marking a 59% decline from its peak and a 46.62% drop over the past year. Despite this, InvestingPro analysis suggests the stock is currently undervalued. The company recently reported better-than-expected Q1 2026 earnings, but analysts have adjusted price targets due to margin concerns and product strategy issues.
A Look At Trupanion (TRUP) Valuation After First Quarter 2026 Earnings Turn To Net Income
Trupanion (TRUP) reported net income of US$4.88 million for Q1 2026, a significant improvement from a net loss in the prior year, yet its year-to-date share price is down 31.21%. While a popular narrative suggests the pet insurer is 44.7% undervalued with a fair value of $46.25, its P/E ratio of 43.3x is considerably higher than the industry average, indicating potential valuation risk. Investors are advised to weigh both the positive earnings development and the high valuation multiple.
Trupanion (NASDAQ: TRUP) director updates 1.44M indirect share holdings after loan default
Trupanion director Darryl Rawlings reported an internal restructuring-related transaction where 1,359 shares of TRUP common stock were transferred to Kuyashii Primary Equities LLC. This transfer occurred on May 6, 2026, due to a loan default where the stock was pledged as collateral. Following this, Kuyashii Primary Equities LLC now indirectly holds 1,435,340 shares for Rawlings, and the filing also corrected a prior reporting error regarding beneficial ownership.
TRUP Earning Date, Earning Analysis and Earning Prediction
This article provides an earnings analysis and prediction for TRUP (Trupanion Inc.), detailing past quarterly results, future forecasts, and stock price reactions to earnings announcements. It highlights analyst estimates for upcoming quarters, the impact of revenue and EPS revisions on stock performance, and historical stock movements around earnings dates. The sentiment for TRUP's Q1 2026 earnings is positive, citing strong financial performance and strategic investments despite veterinary inflation risks.
Trupanion, Inc. Hits New 52-Week Low at $23.91 Amid Market Decline
Trupanion, Inc. recently hit a new 52-week low of $23.91, marking a significant drop despite the broader market's gains. While the stock has underperformed, the company exhibits strong long-term fundamentals, including high growth in operating profits and net sales. Trupanion has a market capitalization of $1,125 million and a P/E ratio of 55.00, suggesting a premium valuation, though its price-to-book ratio is lower than peers.
The 5 Most Interesting Analyst Questions From Trupanion’s Q1 Earnings Call
Trupanion reported strong Q1 results, with adjusted operating income up 29% year-over-year, beating analyst revenue and EPS estimates. Analysts questioned management on topics including the disconnect between software adoption and pet count growth, the relevance of IRR metrics, and the success of new ventures. Management emphasized AOI as a key performance indicator and highlighted strategy around broader coverage options and digital-first product launches.
Life Insurance In Force of Trupanion, Inc. – NASDAQ:TRUP
This article provides financial information for Trupanion, Inc. (NASDAQ: TRUP) focusing on its "Life Insurance In Force" metric. It appears to be a stub or a section from a financial data platform like TradingView, listing links to various financial tools and resources related to the company. The core content is very minimal, essentially just the title and placeholder information.
Life Insurance In Force of Trupanion, Inc. – LSE:0LH0
The article discusses the "Life Insurance In Force" metric for Trupanion, Inc. (LSE:0LH0). It appears to be a financial data point provided by TradingView for the London Stock Exchange listing of Trupanion, Inc. The page structure suggests that more detailed financial data would typically be displayed here.
Trupanion (Nasdaq:TRUP) - Stock Analysis
This Simply Wall St analysis of Trupanion (TRUP) provides a comprehensive overview of the company's financial health, performance, and future outlook. It highlights that Trupanion is currently undervalued by analysts, with strong revenue growth and a forecast to become profitable in 2025. The article also details recent news, insider transactions, and price performance, offering a detailed snapshot for potential investors.
Trupanion (TRUP) Is Down 10.7% After Fourth Straight Profitable Quarter And Record Subscription Margins
Trupanion (TRUP) reported its fourth consecutive profitable quarter and record adjusted operating income, with a swing to net income of US$4.88 million in Q1 2026. Despite these strong results and growing subscription margins, the stock is down 10.7%. The article suggests that while current profitability is strong, underlying risks include potential overreliance on higher average revenue per pet and the impact of rising prices on actual pet growth.
Trupanion (TRUP) Is Down 10.7% After Fourth Straight Profitable Quarter And Record Subscription Margins
Trupanion (TRUP) reported a profitable Q1 2026, swinging to a net income of US$4.88 million with strong subscription margins and record adjusted operating income. Despite these positive financial results, the stock is down 10.7%. The article discusses how these results impact Trupanion's investment narrative, highlighting its subscription model's potential for durable growth against risks like rising prices masking weak pet growth and competition.
Trupanion CEO Margi Tooth Leads the Pack
Margi Tooth, CEO of Trupanion, the largest pet insurer in the U.S., shares her journey from dreaming of being a vet to leading a company that insures over a million pets and generates over $1 billion in annual revenue. She emphasizes the importance of collaboration, building a trusted team, continuous learning, and trusting one's instincts in leadership. Tooth also discusses overcoming workplace barriers and negative self-talk, crediting her mentors and family for their unwavering support.
Is Trupanion, Inc. (TRUP) A Good Stock To Buy Now?
This article summarizes a bullish thesis on Trupanion, Inc. (TRUP), highlighting its subscription-driven pet insurance model, disciplined capital deployment, and potential for long-term intrinsic value growth despite recent margin compression. The company's competitive moat is attributed to its point-of-care distribution and strong retention, with management guiding for 13-15% subscription growth and about 15% margins by FY2026. The article suggests TRUP is an underappreciated compounder with improving economics.
A Look At Trupanion (TRUP) Valuation After Recent Share Price Move
Trupanion (TRUP) has seen a recent 1.4% gain, but longer-term returns have been weaker. Despite a fair value estimate of $46.25 suggesting it's undervalued based on future earnings and technological efficiencies, the company trades at a high P/E ratio of 41x compared to the industry average. Key risks include reliance on price increases and rising competition, urging investors to examine the underlying data beyond just the fair value estimate.
Trupanion (TRUP) Profitability Turn And 41x P/E Test Bullish Earnings Narratives
Trupanion (TRUP) has achieved profitability, reporting Q1 2026 revenue of US$384.0 million and EPS of US$0.11, with a positive trailing net income of US$25.8 million. While bulls view this as an inflection point with projected 19% earnings growth, bears highlight that current quarterly EPS of US$0.11 is modest compared to ambitious multi-year forecasts and the 41x P/E ratio is high against industry averages, suggesting limited room for error if growth expectations are not met.
Analysts Offer Insights on Financial Companies: Trupanion (TRUP) and Galaxy Digital (GLXY)
Cantor Fitzgerald analysts have provided insights on two financial companies: Trupanion (TRUP) and Galaxy Digital (GLXY). For Trupanion, analyst Ryan Tunis maintained a Hold rating and a $34.00 price target, noting a general "Moderate Buy" consensus from analysts with a higher average price target of $40.50. For Galaxy Digital, analyst Brett Knoblauch maintained a Buy rating with a $30.00 price target, contributing to a "Strong Buy" consensus among analysts with an average price target of $38.92.
Analysts Offer Insights on Financial Companies: Trupanion (TRUP) and Galaxy Digital (GLXY)
Cantor Fitzgerald analysts have provided insights on Trupanion (TRUP) and Galaxy Digital (GLXY). Analyst Ryan Tunis maintained a Hold rating on Trupanion, setting a $34.00 price target, while Brett Knoblauch maintained a Buy rating on Galaxy Digital with a $30.00 price target. The article highlights consensus ratings and potential upsides for both companies based on analyst insights.
Analysts Conflicted on These Financial Names: Beacon Financial Corporation (BBT), Suncrete Inc Class A (RMIX) and Trupanion (TRUP)
Analysts are divided on several financial sector companies. Beacon Financial Corporation (BBT) was downgraded to Hold by Raymond James, while Suncrete Inc Class A (RMIX) received a Buy rating from Jefferies. Trupanion (TRUP) maintained a Buy rating from William Blair, with a significant implied upside.
Cantor Fitzgerald Maintains Trupanion(TRUP.US) With Hold Rating, Maintains Target Price $34
Cantor Fitzgerald has reiterated its Hold rating on Trupanion (TRUP.US) and maintained its target price at $34. This indicates that the firm sees the stock as likely to perform in line with the market rather than expecting significant upward or downward movement. Investors will be interested in understanding the rationale behind this steady valuation.
Trupanion Reports First Quarter 2026 Results
Trupanion, Inc. announced its financial results for the first quarter ended March 31, 2026, reporting a total revenue of $384.0 million, a 12% increase year-over-year. The company achieved a net income of $4.9 million, or $0.11 per share, significantly improving from a net loss in the prior year. Trupanion attributes its strong performance to consistent growth in discretionary profit and strategic investments aimed at expanding its offerings and strengthening its market position as a leading provider of pet medical insurance.
Trupanion, Inc. (TRUP) PT Lowered to $28 at Stifel
Stifel analyst Jonathan Block has lowered the price target for Trupanion, Inc. (TRUP) to $28.00 from $31.00. The analyst maintained their rating on the stock. This article is a premium content piece from StreetInsider.com.
Piper Sandler Initiates Trupanion(TRUP.US) With Buy Rating, Announces Target Price $45
Piper Sandler has initiated coverage of Trupanion (TRUP.US) with a Buy rating. The financial firm has set a target price of $45 for the company's stock. This indicates a positive outlook from Piper Sandler regarding Trupanion's future performance.
Trupanion, Inc. (NASDAQ:TRUP) Q1 2026 Earnings Call Transcript
Trupanion, Inc. reported strong Q1 2026 earnings, exceeding expectations with an EPS of $0.11 against a $0.07 forecast and generating over $40 million in adjusted operating income. The company is set to launch a new digital-first product later this year and expand options for its core offering, aiming to broaden its customer base and leverage its adjusted operating income for continued growth. Trupanion also discussed its shift away from blended Internal Rate of Return (IRR) metrics in favor of Adjusted Operating Income (AOI) to better reflect its mature and diversified business, and addressed macro trends like pet adoption and increased cat enrollments.
Trupanion Inc (TRUP) Q1 2026 Earnings Call Highlights: Record Gr
Trupanion Inc. (TRUP) announced strong Q1 2026 results, including a 29% increase in adjusted operating income and expanded pet enrollment. The company is focusing on innovation with a new digital-first product targeting millennials and Gen Z pet owners, while also acknowledging challenges like increased pet acquisition costs and slowing pet adoption trends. Trupanion aims to maintain growth by emphasizing its adjusted operating income and expanding its product offerings to address varying customer needs.
Trupanion Inc (TRUP) Q1 2026 Earnings Call Highlights: Record Growth in Adjusted Operating Income and Pet Enrollment
Trupanion Inc (TRUP) reported a significant 29% year-over-year increase in adjusted operating income for Q1 2026, reaching over $40 million, driven by strong pet enrollment growth and record lifetime value per pet. The company is also expanding its product offerings with a new digital-first solution aimed at millennials and Gen Z pet owners, despite facing challenges such as increased pet acquisition costs and a slowdown in pet adoption trends. Trupanion also stated that the internal rate of return (IRR) is no longer a relevant metric due to increased business complexity.
Trupanion, Inc. Hits New 52-Week Low at $23.93 Amid Market Decline
Trupanion, Inc. recently reached a new 52-week low of $23.93, reflecting a 10.49% stock price drop over the past year, significantly underperforming the S&P 500. Despite this decline, the company shows strong long-term fundamentals with an 85.81% CAGR in operating profits, 23.45% net sales growth, and robust operating cash flow. Trupanion currently holds a market capitalization of $1,125 million with a P/E ratio of 55.00, indicating a premium valuation.
Trupanion (TRUP) Q1 2026 Earnings Transcript
Trupanion reported strong Q1 2026 results, with adjusted operating income up 29% year over year to $40.2 million and total revenue increasing 12% to $384 million. The company is focusing on Adjusted Operating Income (AOI) as its primary financial metric, attributing significant growth to it, and plans to broaden product offerings and launch a new digital-first solution to attract a wider customer base. Trupanion maintains its full-year guidance and remains committed to strategic investments and operational efficiency, including increased claims automation.
Earnings Flash (TRUP) Trupanion, Inc. Reports Q1 Revenue $384.0M, vs. FactSet Est of $379.8M
Trupanion, Inc. (TRUP) announced its Q1 revenue reached $384.0 million, surpassing the FactSet estimate of $379.8 million. The report was published on April 30, 2026, at 04:56 pm EDT. Trupanion provides medical insurance for cats and dogs and operates in various segments including subscription business and other business.
Trupanion (Nasdaq: TRUP) swings to Q1 profit as revenue climbs 12%
Trupanion (TRUP) reported strong first-quarter 2026 results, swinging to a net income of $4.9 million, or $0.11 per share, compared to a net loss in the prior year. This turnaround was driven by a 12% increase in total revenue to $384.0 million, with subscription business revenue growing 16%. The company also achieved a 5% increase in subscription enrolled pets and improved adjusted EBITDA, highlighting a healthy return to profitability and sustained growth in its core business.
Trupanion: Q1 Earnings Snapshot
Trupanion Inc. (TRUP) reported a first-quarter profit of $4.9 million, or 11 cents per share, surpassing Wall Street expectations of 7 cents per share. The pet medical insurance provider also exceeded revenue forecasts, posting $384 million against an expected $379.7 million from analysts surveyed by Zacks Investment Research.
Trupanion faces earnings test as growth efficiency concerns mount By Investing.com
Trupanion Inc. is set to report its first-quarter earnings, with analysts expecting 7 cents per share on $379.7 million in revenue. Investors are keenly watching the company's pet acquisition metrics, loss ratio, and strategy for rebalancing growth between pricing and headcount amidst a competitive market and regulatory changes. Concerns about the durability of margins and growth efficiency have led to recent price-target cuts from major firms.
Stifel Nicolaus Sticks to Their Hold Rating for Trupanion (TRUP)
Stifel Nicolaus analyst Jonathan Block reiterated a Hold rating on Trupanion (TRUP) with a $31.00 price target, citing Trupanion's recent financial performance. The company reported increased quarterly revenue and net profit, but corporate insider sentiment is negative due to increased insider selling. The analyst consensus for Trupanion remains a Moderate Buy with a higher price target of $42.25.
Trupanion (NASDAQ: TRUP) COO sells 431 shares in planned trade
Trupanion's Chief Operating Officer, John R. Gallagher, sold 431 shares of common stock at $27.47 per share. This transaction was conducted under a pre-established Rule 10b5-1 trading plan for financial diversification, meaning the timing was not at his discretion. Following the sale, Gallagher continues to directly hold 31,526 shares of Trupanion stock.
Trupanion (NASDAQ:TRUP) COO Sells $11,839.57 in Stock
Trupanion's COO, John Gallagher, sold 431 shares of the company's stock for $11,839.57 on April 28th, reducing his stake by 1.35%. This transaction leaves him with 31,526 shares valued at approximately $866,019. The company's stock is currently trading near $25.08, with a market cap of $1.09 billion, and has an average "Hold" rating from analysts with a price target of $45.80 despite recent downgrades and a slight earnings per share miss.
Insider Sell: John Gallagher Sells Shares of Trupanion Inc (TRUP)
John Gallagher, Chief Operating Officer of Trupanion Managers USA Inc, sold 431 shares of Trupanion Inc (TRUP) on April 28, 2026. This transaction brings his total holdings to 31,526 shares. The company's stock, trading at $27.47, is considered significantly undervalued with a price-to-GF-Value ratio of 0.67, despite a higher-than-industry-median P/E ratio of 55.73.
Trupanion COO John Gallagher sells $11,839 in common stock
Trupanion COO John Gallagher sold 431 shares of company stock for $11,839 on April 28, 2026, as part of a pre-established trading plan for financial diversification. This transaction follows a 39.83% decline in the stock's value over the past six months, though InvestingPro analysis suggests the stock is undervalued. The company recently reported mixed Q4 2025 earnings and has seen price target reductions from analysts due to growth concerns and increased competition.
